Skip to main content
Canna~Fangled Abstracts

Cannabicitran: Its unexpected racemic nature and potential origins

By May 4, 2023May 8th, 2023No Comments


doi: 10.1002/chir.23571.

Online ahead of print.
Affiliations 

Abstract

Cannabicitran is a cannabinoid found in levels up to ~10% in commercial “purified” cannabidiol (CBD) extracts. The structure of this natural product was first reported more than 50 years ago. However, few studies have investigated cannabicitran or its origin despite the rapidly increasing interest in the use of cannabinoids for the treatment of a wide range of physiological conditions. Following on a recent detailed NMR and computational characterization of cannabicitran, our group initiated ECD and TDDFT studies aimed at unequivocally determining the absolute configuration of cannabicitran present in Cannabis sativa extracts. To our surprise, we discovered the natural product was racemic, raising questions around its presumed enzymatic origin. Herein, we report the isolation and absolute configuration of (-)-cannabicitran and (+)-cannabicitran. Several possible scenarios for production of the racemate in the plant and/or during extract processing are discussed.

Keywords: CBT-C, DFT calculations, ECD, NMR, OR, TDDFT, VCD, cannabicitran, cannabinoids

Similar articles

References

REFERENCES

    1. Vučković S, Srebro D, Vujović KS, Vučetić Č, Prostran M. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;9:1259. doi:10.3389/fphar.2018.01259
    1. Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci. 2018;19(3):833. doi:10.3390/ijms19030833
    1. Schafroth MA, Mazzoccanti G, Reynoso-Moreno I, et al. Δ9-cis-Tetrahydrocannabinol: natural occurrence, chirality, and pharmacology. J Nat Prod. 2021;84:2502-2510. doi:10.1021/acs.jnatprod.1c00513
    1. Morales P, Reggio PH, Jagerovic N. An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol. Front Pharmacol. 2017;8:422. doi:10.3389/fphar.2017.00422
    1. Bisogno T, Hanuš L, Petrocellis LD, et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol. 2009;134(4):845-852. doi:10.1038/sj.bjp.0704327

LinkOut – more resources

  • Full Text Sources



 

Leave a Reply